By Associate Professor Megan Amanda Crumbaker

Other

Talmor B; Marastoni S; Lau B; Yam AO; Yeung N; Lin H-M; Li ZJ; Woo H; Pranavan G; Stricker PD; Horvath LG; Koritzinsky M; Wouters BG; Crumbaker M; Joshua AM, 2026, Data from A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results, http://dx.doi.org/10.1158/2767-9764.c.8387594

Talmor B; Marastoni S; Lau B; Yam AO; Yeung N; Lin H-M; Li ZJ; Woo H; Pranavan G; Stricker PD; Horvath LG; Koritzinsky M; Wouters BG; Crumbaker M; Joshua AM, 2026, Figure 1 from A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results, http://dx.doi.org/10.1158/2767-9764.31872536

Talmor B; Marastoni S; Lau B; Yam AO; Yeung N; Lin H-M; Li ZJ; Woo H; Pranavan G; Stricker PD; Horvath LG; Koritzinsky M; Wouters BG; Crumbaker M; Joshua AM, 2026, Figure 2 from A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results, http://dx.doi.org/10.1158/2767-9764.31872533

Talmor B; Marastoni S; Lau B; Yam AO; Yeung N; Lin H-M; Li ZJ; Woo H; Pranavan G; Stricker PD; Horvath LG; Koritzinsky M; Wouters BG; Crumbaker M; Joshua AM, 2026, Figure 3 from A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results, http://dx.doi.org/10.1158/2767-9764.31872530

Talmor B; Marastoni S; Lau B; Yam AO; Yeung N; Lin H-M; Li ZJ; Woo H; Pranavan G; Stricker PD; Horvath LG; Koritzinsky M; Wouters BG; Crumbaker M; Joshua AM, 2026, Figure 4 from A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results, http://dx.doi.org/10.1158/2767-9764.31872527

Talmor B; Marastoni S; Lau B; Yam AO; Yeung N; Lin H-M; Li ZJ; Woo H; Pranavan G; Stricker PD; Horvath LG; Koritzinsky M; Wouters BG; Crumbaker M; Joshua AM, 2026, Supplementary Figure 1 from A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results, http://dx.doi.org/10.1158/2767-9764.31872524

Talmor B; Marastoni S; Lau B; Yam AO; Yeung N; Lin H-M; Li ZJ; Woo H; Pranavan G; Stricker PD; Horvath LG; Koritzinsky M; Wouters BG; Crumbaker M; Joshua AM, 2026, Supplementary Figure 2 from A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results, http://dx.doi.org/10.1158/2767-9764.31872521

Talmor B; Marastoni S; Lau B; Yam AO; Yeung N; Lin H-M; Li ZJ; Woo H; Pranavan G; Stricker PD; Horvath LG; Koritzinsky M; Wouters BG; Crumbaker M; Joshua AM, 2026, Supplementary Figure 3 from A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results, http://dx.doi.org/10.1158/2767-9764.31872518

Talmor B; Marastoni S; Lau B; Yam AO; Yeung N; Lin H-M; Li ZJ; Woo H; Pranavan G; Stricker PD; Horvath LG; Koritzinsky M; Wouters BG; Crumbaker M; Joshua AM, 2026, Supplementary Figure 4 from A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results, http://dx.doi.org/10.1158/2767-9764.31872515

Talmor B; Marastoni S; Lau B; Yam AO; Yeung N; Lin H-M; Li ZJ; Woo H; Pranavan G; Stricker PD; Horvath LG; Koritzinsky M; Wouters BG; Crumbaker M; Joshua AM, 2026, Supplementary Figure 5 from A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results, http://dx.doi.org/10.1158/2767-9764.31872512

Talmor B; Marastoni S; Lau B; Yam AO; Yeung N; Lin H-M; Li ZJ; Woo H; Pranavan G; Stricker PD; Horvath LG; Koritzinsky M; Wouters BG; Crumbaker M; Joshua AM, 2026, Supplementary Figure 6 from A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results, http://dx.doi.org/10.1158/2767-9764.31872509

Talmor B; Marastoni S; Lau B; Yam AO; Yeung N; Lin H-M; Li ZJ; Woo H; Pranavan G; Stricker PD; Horvath LG; Koritzinsky M; Wouters BG; Crumbaker M; Joshua AM, 2026, Supplementary Table 1 from A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results, http://dx.doi.org/10.1158/2767-9764.31872506

Talmor B; Marastoni S; Lau B; Yam AO; Yeung N; Lin H-M; Li ZJ; Woo H; Pranavan G; Stricker PD; Horvath LG; Koritzinsky M; Wouters BG; Crumbaker M; Joshua AM, 2026, Supplementary Table 2 from A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results, http://dx.doi.org/10.1158/2767-9764.31872503

Talmor B; Marastoni S; Lau B; Yam AO; Yeung N; Lin H-M; Li ZJ; Woo H; Pranavan G; Stricker PD; Horvath LG; Koritzinsky M; Wouters BG; Crumbaker M; Joshua AM, 2026, Table 1 from A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results, http://dx.doi.org/10.1158/2767-9764.31872500

Talmor B; Marastoni S; Lau B; Yam AO; Yeung N; Lin H-M; Li ZJ; Woo H; Pranavan G; Stricker PD; Horvath LG; Koritzinsky M; Wouters BG; Crumbaker M; Joshua AM, 2026, Table 2 from A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results, http://dx.doi.org/10.1158/2767-9764.31872497

Back to profile page